Intrinsic Value of S&P & Nasdaq Contact Us

CannLabs, Inc. CANL OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
80/100
5/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CANL

CannLabs, Inc. (CANL) has a market capitalization of $93.32K and trades at $0.00. The 52-week range is 0.0001-0.01.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.1, Earnings Per Share (EPS) of $0.00, annual revenue of $4.39M.

The stock has a beta of 5.59, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0001-0.01
Volume100
Avg Volume (30D)660
Market Cap$93.32K
Beta (1Y)5.59
Company
IPO Date2014-06-13
Employees37
CEOMark C. Mirken
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS13767T1025
CUSIP13767T102
Income (Latest Year)
Revenue$4.39M
Gross Profit$2.06M
EBITDA$880.66K
Operating Income$872.24K
Net Income$869.17K
EPS$0.00
EPS Diluted$0.00
Shares Outstanding$813.16M
Balance Sheet (Latest Year)
Total Assets$3.25M
Current Assets$2.3M
Cash & ST Investments$651.03K
Total Liabilities$846.12K
Net Debt$-651.03K
Total Equity$2.4M
Valuation Ratios
P/E Ratio0.1
P/S Ratio0.02
P/B Ratio0.04
EV/EBITDA (approx)0.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message